The trajectory of Viagra presents a intricate picture for shareholders. While the initial introduction generated significant returns, the end of its exclusive rights opened the door to cheaper competitors, dramatically https://nimmansocial.com/story11749530/the-copyright-and-big-pharma-a-precarious-investment